Dyrness Albert D. 4
4 · Oncobiologics, Inc. · Filed Oct 30, 2017
Insider Transaction Report
Form 4
Dyrness Albert D.
Director
Transactions
- Award
Stock Option (Right to Buy)
2017-10-26+15,000→ 15,000 totalExercise: $1.32Exp: 2027-10-26→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]100% of the shares underlying the option shall vest on October 26, 2018, subject to the Reporting Person providing continuous service to the Issuer on such date.